Chemed Corporation (CHE) Income Statement
CHE 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsCHE revenue and net income
Where CHE's revenue goes
2025Each bar shows an amount and its share of revenue. CHE kept 10.5% of revenue as net income.
CHE profit margins
CHE growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +4.1% | +5.8% | +4.0% | +5.1% |
| Gross profit | −11.2% | −0.3% | +1.6% | +5.2% |
| Operating income | −7.7% | −0.5% | −2.8% | +6.3% |
| Net income | −12.2% | +2.0% | −3.7% | +9.2% |
| EPS (diluted) | −6.7% | +3.0% | +3.6% | +11.9% |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
CHE quarterly EPS vs estimates
Chemed beat the analyst EPS estimate in 4 of the last 8 quarters. Next report: October 27, 2026 (estimate $5.93).
CHE income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.53B | $2.43B | $2.26B | $2.13B | $2.14B | $2.08B | $1.94B | $1.78B | $1.67B | $1.58B |
| Cost of revenue | $1.77B | $1.58B | $1.47B | $1.37B | $1.37B | $1.38B | $1.32B | $1.23B | $1.15B | $1.12B |
| Gross profit | $758.3M | $854.3M | $798.8M | $765.1M | $769.8M | $701.4M | $617.4M | $555.0M | $516.2M | $461.4M |
| Research & development | — | — | — | — | — | — | — | $0 | $0 | $0 |
| Sales, general & admin | $417.2M | $497.5M | $467.3M | $420.4M | $428.8M | $330.2M | $355.2M | $271.2M | $317.6M | $285.3M |
| Total operating expenses | $417.2M | $487.9M | $458.2M | $421.6M | $426.8M | $311.7M | $360.0M | $311.4M | $403.2M | $282.7M |
| Operating income | $338.2M | $366.5M | $340.6M | $343.5M | $343.0M | $389.7M | $257.4M | $243.6M | $113.0M | $178.7M |
| Interest income | $8.7M | $14.6M | $2.9M | $14.2M | $6.8M | $757,000 | $513,000 | $671,000 | $427,000 | $383,000 |
| Interest expense | $1.8M | $1.8M | $3.1M | $4.6M | $1.9M | $2.4M | $4.5M | $5.0M | $4.3M | $3.7M |
| Income before taxes | $355.8M | $399.5M | $350.4M | $329.7M | $350.3M | $396.0M | $261.6M | $239.6M | $116.9M | $177.1M |
| Income taxes | $90.5M | $97.5M | $77.9M | $80.1M | $81.8M | $76.5M | $41.7M | $34.1M | $18.7M | $68.3M |
| Net income | $265.2M | $302.0M | $272.5M | $249.6M | $268.6M | $319.5M | $219.9M | $205.5M | $98.2M | $108.7M |
| EBITDA | $422.4M | $464.3M | $414.3M | $393.4M | $411.2M | $454.9M | $311.3M | $283.5M | $156.8M | $215.4M |
| EPS (diluted) | $21.59 | $23.14 | $21.45 | $19.76 | $19.35 | $18.08 | $13.96 | $11.95 | $8.44 | $7.25 |
| Gross margin | 30.0% | 35.1% | 35.3% | 35.8% | 36.0% | 33.7% | 31.8% | 31.1% | 31.0% | 29.3% |
| Operating margin | 13.4% | 15.1% | 15.0% | 16.1% | 16.0% | 18.7% | 13.3% | 13.7% | 6.8% | 11.3% |
| Net margin | 10.5% | 12.4% | 12.0% | 11.7% | 12.6% | 15.4% | 11.3% | 11.5% | 5.9% | 6.9% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $673.3M | $657.5M | $639.3M | $624.9M | $618.8M | $646.9M | $640.0M | $606.2M | $595.9M | $589.2M | $585.9M | $564.5M |
| Cost of revenue | $468.8M | $458.6M | $433.3M | $444.2M | $434.1M | $430.5M | $405.9M | $396.2M | $389.8M | $385.1M | $358.3M | $362.4M |
| Gross profit | $204.4M | $198.9M | $206.0M | $180.7M | $184.7M | $216.4M | $234.1M | $210.0M | $206.1M | $204.1M | $227.6M | $202.2M |
| Sales, general & admin | — | $114.3M | $105.5M | $105.8M | $118.3M | $105.6M | $104.3M | $104.6M | $102.3M | $115.9M | $105.9M | $99.6M |
| Total operating expenses | $115.2M | $114.3M | $105.5M | $105.8M | $116.6M | $121.7M | $120.2M | $117.8M | $118.0M | $131.8M | $116.2M | $115.3M |
| Operating income | $89.2M | $84.6M | $100.7M | $74.8M | $68.1M | $94.8M | $113.9M | $92.2M | $88.1M | $72.3M | $111.4M | $86.8M |
| Interest income | — | $890,000 | $1.6M | $2.6M | $3.0M | $2.1M | $3.2M | $3.7M | $3.5M | $4.2M | $3.4M | $2.6M |
| Interest expense | $1.8M | $512,000 | $521,000 | $2.0M | $443,000 | $329,000 | $499,000 | $427,000 | $429,000 | $425,000 | $342,000 | $444,000 |
| Income before taxes | $91.3M | $88.8M | $105.4M | $83.5M | $71.1M | $95.7M | $120.1M | $101.0M | $93.8M | $84.5M | $115.6M | $93.3M |
| Income taxes | $23.6M | $22.5M | $28.7M | $19.3M | $18.6M | $23.9M | $29.8M | $25.3M | $22.9M | $19.5M | $25.5M | $18.3M |
| Net income | $67.7M | $66.3M | $76.8M | $64.2M | $52.5M | $71.8M | $90.3M | $75.8M | $70.9M | $65.0M | $90.1M | $75.0M |
| EBITDA | $101.4M | $106.2M | $122.3M | $101.8M | $87.8M | $112.0M | $136.5M | $117.2M | $110.0M | $100.7M | $131.5M | $109.1M |
| EPS (diluted) | $5.52 | $5.65 | $6.42 | $5.27 | $4.27 | $5.63 | $6.83 | $5.64 | $5.47 | $5.20 | $6.60 | $5.32 |
| Gross margin | 30.4% | 30.2% | 32.2% | 28.9% | 29.8% | 33.5% | 36.6% | 34.6% | 34.6% | 34.6% | 38.8% | 35.8% |
| Operating margin | 13.2% | 12.9% | 15.7% | 12.0% | 11.0% | 14.6% | 17.8% | 15.2% | 14.8% | 12.3% | 19.0% | 15.4% |
| Net margin | 10.1% | 10.1% | 12.0% | 10.3% | 8.5% | 11.1% | 14.1% | 12.5% | 11.9% | 11.0% | 15.4% | 13.3% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in CHE's financial statements (latest annual report filed February 27, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
CHE financial results
In fiscal year 2025 (ended December 31, 2025), Chemed reported revenue of $2.5 billion, up 4.1% from the year before. It had net income of $265.2 million (down 12.2%), a net profit margin of 10.5%. Diluted earnings per share came to $21.59. Over five years revenue grew at an average rate of 4.0% a year.
See the CHE stock overview for the latest quote and news, or the CHE chart for price history and technical indicators.
CHE income statement FAQ
What is Chemed's annual revenue?
Chemed reported total revenue of $2.5 billion for fiscal year 2025, which ended on December 31, 2025. That was up 4.1% from $2.4 billion the previous year.
Is Chemed profitable?
Yes. Chemed reported net income of $265.2 million in fiscal 2025, a net profit margin of 10.5%; its operating margin was 13.4%.
What is Chemed's gross margin?
Chemed's gross margin was 30.0% in fiscal 2025: for every $100 of revenue, Chemed kept $30 after the direct cost of its products and services.
How fast is Chemed growing?
Revenue grew 4.0% a year on average over the last five fiscal years, from $2.1 billion to $2.5 billion.
What are Chemed's earnings per share?
Chemed earned $21.59 per diluted share in fiscal 2025, compared with $23.14 a year earlier.
When will Chemed report its next earnings?
Chemed is expected to report results for the quarter ending September 30, 2026 on October 27, 2026 after the market closes.
When does Chemed's fiscal year end?
Chemed's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 27, 2026.